PI
ALDX icon

PFG Investments’s Aldeyra Therapeutics ALDX Stock Holding History

PFG Investments’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-15,500
Closed -$80.3K – 1194
2025
Q4 		$80.3K Sell
15,500
-50,500
-77% -$259K ﹤0.01% 1101
2025
Q3 		$345K Sell
66,000
-191,300
-74% -$998K 0.02% 713
2025
Q2 		$985K Buy
257,300
+205,550
+397% +$531K 0.06% 313
2025
Q1 		$298K Sell
51,750
-295,997
-85% -$1.75M 0.02% 713
2024
Q4 		$1.74M Sell
347,747
-38,700
-10% -$199K 0.11% 182
2024
Q3 		$2.08M Sell
386,447
-9,800
-2% -$46.6K 0.13% 151
2024
Q2 		$1.31M Buy
+396,247
New +$1.55M 0.09% 207
2023
Q4 		– Sell
-10,500
Closed -$70.1K – 486
2023
Q3 		$70.1K Hold
10,500
– – 0.01% 487
2023
Q2 		$88.1K Hold
10,500
– – 0.02% 491
2023
Q1 		$104K Buy
+10,500
New +$74.2K 0.02% 463

Other funds holding ALDX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PFG Investments's ALDX Position: Q1 2026 in Review

PFG Investments sold out of Aldeyra Therapeutics (ALDX) in Q1 2026, closing a stake of 15,500 shares — an estimated $80.3K sold.

PFG Investments first reported a position in ALDX in Q1 2023 and held it in 10 quarters. The position peaked at $2.08M in Q3 2024. 126 funds tracked by Wall St. Rank hold ALDX as of Q1 2026.

  • PFG Investments reported no remaining Aldeyra Therapeutics position as of Q1 2026 after selling out during the quarter.
  • PFG Investments sold 15,500 Aldeyra Therapeutics shares in Q1 2026, an estimated $80.3K.
  • PFG Investments first reported a position in Aldeyra Therapeutics in Q1 2023 and held it in 10 quarters.
  • PFG Investments's Aldeyra Therapeutics position peaked at $2.08M in Q3 2024.
  • 126 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2026.

Based on PFG Investments's 13F filing for Q1 2026, filed 27 Apr 2026.